The characteristics of patients with chronic hepatitis B in Turkey.
暂无分享,去创建一个
B. Aygen | F. Tabak | Y. Onlen | S. Tosun | T. Dal | O. Karabay | H. Turgut | C. Ayaz | I. Koksal | S. Tekin Koruk | Necmettin Yildirim | İ. Balık | Mustafa Kemal Celen | Mehmet Sinan Dal
[1] Gretchen A. Stevens,et al. The risk of perinatal hepatitis B virus transmission: hepatitis B e antigen (HBeAg) prevalence estimates for all world regions , 2012, BMC Infectious Diseases.
[2] G. Borsboom,et al. Age- and region-specific hepatitis B prevalence in Turkey estimated using generalized linear mixed models: a systematic review , 2011, BMC infectious diseases.
[3] B. Aygen,et al. Lamivudine resistance mutations in patients infected with hepatitis B virus genotype D. , 2011, World journal of gastroenterology.
[4] S. Hutchinson,et al. Hepatitis B prevention, diagnosis, treatment and care: a review. , 2011, Occupational medicine.
[5] N. Gozel,et al. Prevalence of hepatitis delta virus (HDV) infection in chronic hepatitis B patients in eastern Turkey: still a serious problem to consider , 2011, Journal of viral hepatitis.
[6] Z. Said. An overview of occult hepatitis B virus infection. , 2011, World journal of gastroenterology.
[7] Muhammad Idrees,et al. Hepatitis B virus in Pakistan: A systematic review of prevalence, risk factors, awareness status and genotypes , 2011, Virology Journal.
[8] R. Merrill,et al. Seroprevalence of markers for hepatitis B viral infection. , 2011, International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases.
[9] Z. Abbas,et al. Prevalence of hepatitis D in HBsAg positive patients visiting liver clinics. , 2009, JPMA. The Journal of the Pakistan Medical Association.
[10] S. Farhang,et al. The frequency of hepatitis D virus in patients with hepatitis B in Iran: an increasing rate? , 2009, Tropical doctor.
[11] I. Gareen,et al. National Institutes of Health consensus development conference statement: Management of hepatitis B , 2009, Hepatology.
[12] M. Hussain,et al. The increasing prevalence of hepatitis delta virus (HDV) infection in South London , 2008, Journal of medical virology.
[13] D. Toprak,et al. Hepatitis B and C virus in West-Central Turkey: seroprevalence in healthy individuals admitted to a university hospital for routine health checks. , 2006, The Turkish journal of gastroenterology : the official journal of Turkish Society of Gastroenterology.
[14] C. Saban,et al. Trends in Hepatitis B and Hepatitis C Virus among Blood Donors over 16 Years in Turkey , 2006, European Journal of Epidemiology.
[15] Y. Liaw. The current management of HBV drug resistance. , 2005, Journal of clinical virology : the official publication of the Pan American Society for Clinical Virology.
[16] H. Leblebicioglu,et al. Distribution of hepatitis B virus genotypes in patients with chronic hepatitis B in Turkey. , 2005, World journal of gastroenterology.
[17] Mei Huang,et al. YMDD mutations in patients with chronic hepatitis B untreated with antiviral medicines. , 2005, World journal of gastroenterology.
[18] Dursun Mehmet,et al. Prevalence of hepatitis B infection in the southeastern region of Turkey: comparison of risk factors for HBV infection in rural and urban areas. , 2005, Japanese journal of infectious diseases.
[19] MustafaSunbul,et al. Distribution of hepatitis B virus genotypes in patients with chronic hepatitis B in Turkey , 2005 .
[20] W. Hou,et al. Character of HBV (hepatitis B virus) polymerase gene rtM204V/I and rtL180M mutation in patients with lamivudine resistance. , 2005, Journal of Zhejiang University. Science. B.
[21] B. Donovan. Sexually transmissible infections other than HIV , 2004, The Lancet.
[22] T. Wright. Clinical trial results and treatment resistance with lamivudine in hepatitis B. , 2004, Seminars in liver disease.
[23] Man-Fung Yuen,et al. Viral hepatitis B , 2003, The Lancet.
[24] Yoshiyuki Suzuki,et al. Low rate of YMDD motif mutations in polymerase gene of hepatitis B virus in chronically infected patients not treated with lamivudine , 2003, Journal of Gastroenterology.
[25] A. Lok,et al. World‐wide epidemiology of HBeAg‐negative chronic hepatitis B and associated precore and core promoter variants , 2002, Journal of viral hepatitis.
[26] B. McMahon,et al. Serologic and Clinical Outcomes of 1536 Alaska Natives Chronically Infected with Hepatitis B Virus , 2001, Annals of Internal Medicine.
[27] D. Vassilopoulos,et al. Hepatitis B e antigen–negative chronic hepatitis B , 2001, Hepatology.
[28] E. Kırımi,et al. Seroepidemiology of Hepatitis B Virus Infection in Children in The Eastern Anatolia , 2001 .
[29] A. Kence,et al. Polymorphism of Precore Region of Hepatitis B Virus DNA among Patients with Chronic HBV Infection in Turkey , 1999, Infection.
[30] F. Mahoney,et al. Update on Diagnosis, Management, and Prevention of Hepatitis B Virus Infection , 1999, Clinical Microbiology Reviews.
[31] E. Sagnelli,et al. Decrease in HDV endemicity in Italy. , 1997, Journal of hepatology.
[32] M. Kane. Global programme for control of hepatitis B infection. , 1995, Vaccine.
[33] R. Lambotte. [Sexually transmissible diseases other than AIDS]. , 1994, Revue medicale de Liege.